当前位置:首页 - 行情中心 - 悦康药业(688658) - 财务分析 - 现金流量表

悦康药业

(688658)

  

流通市值:72.41亿  总市值:72.41亿
流通股本:4.50亿   总股本:4.50亿

现金流量表

报告期2024-09-302024-06-302024-03-312023-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
销售商品、提供劳务收到的现金3,220,206,476.272,137,128,714.861,075,653,051.424,730,583,906.34
收到的税费返还21,973,726.353,416,650.396,037.3334,924,383.38
收到其他与经营活动有关的现金84,732,787.4746,422,164.8124,236,537.92110,819,768.92
经营活动现金流入的平衡项目0000
经营活动现金流入小计3,326,912,990.092,186,967,530.061,099,895,626.674,876,328,058.64
购买商品、接受劳务支付的现金942,665,986.88606,569,930.5315,666,537.631,450,056,196.21
支付给职工以及为职工支付的现金338,110,602.64233,775,940.62121,316,932.59447,643,265.18
支付的各项税费276,388,368.4195,317,430.9994,872,705.47393,051,490.49
支付其他与经营活动有关的现金1,339,262,185.77909,791,637.64421,908,553.711,800,085,524.22
经营活动现金流出的平衡项目0000
经营活动现金流出小计2,896,427,143.691,945,454,939.75953,764,729.44,090,836,476.1
经营活动产生的现金流量净额平衡项目0000
经营活动产生的现金流量净额430,485,846.4241,512,590.31146,130,897.27785,491,582.54
二、投资活动产生的现金流量:
处置固定资产、无形资产和其他长期资产收回的现金净额1,315,297.18467,752.05124,802.052,474,166.84
处置子公司及其他营业单位收到的现金净额---8,456,769.3
投资活动现金流入的平衡项目0000
投资活动现金流入小计1,315,297.18467,752.05124,802.0510,930,936.14
购建固定资产、无形资产和其他长期资产支付的现金258,419,986.01182,676,399.1190,961,646.48497,477,682.58
投资支付的现金63,006,50010,000,000-15,500,000
投资活动现金流出的平衡项目0000
投资活动现金流出小计321,426,486.01192,676,399.1190,961,646.48512,977,682.58
投资活动产生的现金流量净额平衡项目0000
投资活动产生的现金流量净额-320,111,188.83-192,208,647.06-90,836,844.43-502,046,746.44
三、筹资活动产生的现金流量:
取得借款收到的现金457,673,304.58317,229,128.7281,730,725387,292,022
收到其他与筹资活动有关的现金66,000,00066,000,000--
筹资活动现金流入平衡项目0000
筹资活动现金流入小计523,673,304.58383,229,128.7281,730,725387,292,022
偿还债务支付的现金218,615,70894,851,83363,000,000247,600,000
分配股利、利润或偿付利息支付的现金103,843,133.0799,052,344.614,437,371.06505,117,864.3
支付其他与筹资活动有关的现金204,469,831.08201,395,093.5625,026,784.4866,766,205.38
筹资活动现金流出平衡项目0000
筹资活动现金流出小计526,928,672.15395,299,271.1792,464,155.54819,484,069.68
筹资活动产生的现金流量净额平衡项目0000
筹资活动产生的现金流量净额-3,255,367.57-12,070,142.47189,266,569.46-432,192,047.68
四、汇率变动对现金及现金等价物的影响502,565.99572,913.37120,751.253,935,520.17
现金及现金等价物净增加额平衡项目0000
五、现金及现金等价物净增加额107,621,855.9937,806,714.15244,681,373.55-144,811,691.41
加:期初现金及现金等价物余额1,373,533,190.291,373,533,190.291,373,533,190.291,518,344,881.7
期末现金及现金等价物余额平衡项目0000
期末现金及现金等价物余额1,481,155,046.281,411,339,904.441,618,214,563.841,373,533,190.29
补充资料:
净利润-117,945,793.07-187,494,090.53
资产减值准备-20,450,476.94-62,405,526.2
固定资产和投资性房地产折旧-86,562,534.99-146,494,090.92
其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-86,562,534.99-146,494,090.92
无形资产摊销-11,390,673.21-21,639,039.85
长期待摊费用摊销-1,969,695.67-2,183,943.56
处置固定资产、无形资产和其他长期资产的损失--205,252.61--1,043,142.4
固定资产报废损失-1,089,593.5-3,491,871.15
公允价值变动损失---686,875.22
财务费用-10,849,144.42-9,276,022.83
投资损失----606,257.43
递延所得税-3,123,544.4--2,576,326.86
其中:递延所得税资产减少-3,123,544.4--2,576,326.86
存货的减少--35,637,045.89--30,606,325.52
经营性应收项目的减少-195,234,641.41-278,300,679.64
经营性应付项目的增加--169,303,046.69-148,970,116.66
其他----37,211,737.8
现金的期末余额-1,411,339,904.44-1,373,533,190.29
减:现金的期初余额-1,373,533,190.29-1,518,344,881.7
公告日期2024-10-312024-08-232024-04-302024-04-30
审计意见(境内)标准无保留意见
TOP↑